1. |
Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Arch, 2008, 452(2): 119-132.
|
2. |
贺亚琼, 姚景江, 刘建滨, 等. 肝脏血管周上皮样细胞肿瘤的病理与 MSCT 表现. 临床放射学杂志, 2019, 38(1): 105-109.
|
3. |
Stone CH, Lee MW, Amin MB, et al. Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med, 2001, 125(6): 751-758.
|
4. |
方三高, 魏建国, 陈真伟. WHO(2020)软组织肿瘤分类. 临床与实验病理学杂志, 2020, 36(9): 1132-1134.
|
5. |
宣兰兰, 魏建国, 刘红刚. 血管周上皮样细胞肿瘤的病理诊断及新进展. 中华病理学杂志, 2021, 50(3): 282-287.
|
6. |
Yamasaki S, Tanaka S, Fujii H, et al. Monotypic epithelioid angiomyolipoma of the liver. Histopathology, 2000, 36(5): 451-456.
|
7. |
刘霞, 卿松, 曹峻, 等. 原发肝脏血管周上皮细胞肿瘤的病理学观察. 中华病理学杂志, 2014, 43(8): 558-559.
|
8. |
陈平平, 张震生, 郑进方, 等. 肝脏血管周上皮样细胞瘤误诊 1 例报告并文献复习. 中国现代手术学杂志, 2020, 24(2): 90-93.
|
9. |
Nie P, Wu J, Wang H, et al. Primary hepatic perivascular epithelioid cell tumors: imaging findings with histopathological correlation. Cancer Imaging, 2019, 19(1): 32.
|
10. |
Pan CC, Chung MY, Ng KF, et al. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol, 2008, 214(3): 387-393.
|
11. |
Fricke BL, Donnelly LF, Casper KA, et al. Frequency and imaging appearance of hepatic angiomyolipomas in pediatric and adult patients with tuberous sclerosis. AJR Am J Roentgenol, 2004, 182(4): 1027-1030.
|
12. |
Zeng JP, Dong JH, Zhang WZ, et al. Hepatic angiomyolipoma: a clinical experience in diagnosis and treatment. Dig Dis Sci, 2010, 55(11): 3235-3240.
|
13. |
陈孟达, 汪玲, 李强, 等. 肝脏上皮样血管周细胞瘤的 CT 和 MRI 特征分析. 医学影像学杂志, 2018, 28(6): 967-970.
|
14. |
骆必伟, 张育森, 杜志勇, 等. 17 例肝脏血管周上皮样细胞肿瘤临床分析. 中华肝胆外科杂志, 2021, 27(11): 819-822.
|
15. |
王国禹, 赵闯, 侯登峰, 等. 肝脏血管周上皮样细胞瘤 11 例临床诊治分析. 中华医学杂志, 2018, 98(34): 2715-2717.
|
16. |
马英腾, 沈丹华. 肝脏血管周上皮样细胞肿瘤临床与病理学特征分析. 中华普通外科杂志, 2017, 32(12): 1007-1009.
|
17. |
黄晓华, 张智弘, 范钦和, 等. 肝脏伴上皮样分化的血管周细胞肿瘤临床病理分析. 中华病理学杂志, 2015(8): 605-607.
|
18. |
吴云飞, 刘健红, 葛振华, 等. 肝脏血管周上皮样细胞肿瘤(Pecoma)临床病理分析并文献复习. 数理医药学杂志, 2015(3): 360-361.
|
19. |
Wang XT, Xia QY, Ni H, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol, 2017, 63: 190-200.
|
20. |
Gulavita P, Fletcher CDM, Hirsch MS. PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours. Histopathology, 2018, 72(3): 441-448.
|
21. |
Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol, 2005, 29(12): 1558-1575.
|
22. |
Yang X, Wang Q, Zhou X, et al. Retrospective analysis of hepatic perivascular epithelioid cell tumour (PEComa) in a single centre for clinical diagnosis and treatment clinical diagnosis and treatment of hepatic PEComa. Medicine (Baltimore), 2022, 101(25): e29506.
|
23. |
张淑红, 黄受方, 陆鸣, 等. 血管周上皮样细胞肿瘤的临床病理学观察. 临床和实验医学杂志, 2011, 10(15): 1149-1152.
|
24. |
张彩, 潘飞豹, 赵纯全. 血管周上皮样细胞肿瘤的临床病理研究进展. 重庆医学, 2014(16): 2081-2083.
|
25. |
Purwar R, Soni K, Shukla M, et al. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review. World J Surg Oncol, 2022, 20(1): 62.
|
26. |
Yang X, Li A, Wu M. Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases. Med Oncol, 2013, 30(1): 416.
|
27. |
Yang CY, Ho MC, Jeng YM, et al. Management of hepatic angiomyolipoma. J Gastrointest Surg, 2007, 11(4): 452-457.
|
28. |
Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver: a collective review. J Gastroenterol, 1994, 29(1): 95-105.
|
29. |
Mai KT, Belanger EC. Perivascular epithelioid cell tumour (PEComa) of the soft tissue. Pathology, 2006, 38(5): 415-420.
|
30. |
Song Z, Xu F, Dai C. Chills and fever as the first presentation of hepatic perivascular epithelioid cell tumor. Hepatobiliary Surg Nutr, 2019, 8(4): 436-438.
|
31. |
陈翼, 董丽华, 李江城, 等. 肝血管周上皮细胞瘤的多种影像表现. 医学影像学杂志, 2017, 27(7): 1405-1409.
|
32. |
Kwon BS, Suh DS, Lee NK, et al. Two cases of perivascular epithelioid cell tumor of the uterus: clinical, radiological and pathological diagnostic challenge. Eur J Med Res, 2017, 22(1): 7.
|
33. |
Tan Y, Xiao EH. Hepatic perivascular epithelioid cell tumor (PEComa): dynamic CT, MRI, ultrasonography, and pathologic features-analysis of 7 cases and review of the literature. Abdom Imaging, 2012, 37(5): 781-787.
|
34. |
Wildgruber M, Becker K, Feith M, et al. Perivascular epitheloid cell tumor (PEComa) mimicking retroperitoneal liposarcoma. World J Surg Oncol, 2014, 12: 3.
|
35. |
Cong X, Zhang J, Xu X, et al. Renal epithelioid angiomyolipoma: magnetic resonance imaging characteristics. Abdom Radiol (NY), 2018, 43(10): 2756-2763.
|
36. |
Wang SY, Kuai XP, Meng XX, et al. Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma. Abdom Imaging, 2014, 39(2): 323-333.
|
37. |
何璐, 覃玲艳, 周梦琦, 等. 肝脏血管周上皮样细胞肿瘤的多模态影像学表现与病理对照分析. 临床放射学杂志, 2021, 40(5): 913-917.
|
38. |
韩伟, 候雪琴, 宋涛, 等. 肝脏血管周上皮细胞肿瘤与肝细胞肝癌及肝血管瘤的超声特征分析. 中国临床医学影像杂志, 2021, 32(5): 342-346,355.
|
39. |
Phillips CH, Keraliya AR, Shinagare AB, et al. Update on the imaging of malignant perivascular epithelioid cell tumors (PEComas). Abdom Radiol (NY), 2016, 41(2): 368-376.
|
40. |
杜锐, 赵年, 陈晓荣, 等. 肝脏恶性血管周上皮样细胞肿瘤并术后复发转移 1 例. 湖北医药学院学报, 2021, 40(3): 300-302, 封 3.
|
41. |
Yang X, Lei C, Qiu Y, et al. Selecting a suitable surgical treatment for hepatic angiomyolipoma: a retrospective analysis of 92 cases. ANZ J Surg, 2018, 88(9): E664-E669.
|
42. |
刘河, 刘浩, 石荣, 等. 肝脏血管周上皮样细胞瘤的诊治分析. 中国现代医学杂志, 2021, 31(7): 22-27.
|
43. |
Akitake R, Kimura H, Sekoguchi S, et al. Perivascular epithelioid cell tumor (PEComa) of the liver diagnosed by contrast-enhanced ultrasonography. Intern Med, 2009, 48(24): 2083-2086.
|
44. |
赵秀丽, 胡儒华, 王平怀, 等. 肝脏血管周上皮样细胞瘤的 CT 和 MRI 表现. 中国医学影像学杂志, 2016, 24(9): 669-673.
|
45. |
唐玉德, 刘树学, 张雄彪, 等. 肝脏局灶性结节增生的 MRI 表现及随访观察. 实用放射学杂志, 2015(9): 1471-1474.
|
46. |
Kirste S, Kayser G, Zipfel A, et al. Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection. Radiat Oncol, 2018, 13(1): 28.
|
47. |
张晓妮, 傅潇, 任梦迪, 等. 血管周上皮样细胞肿瘤的研究进展. 现代肿瘤医学, 2022, 30(8): 1517-1520.
|
48. |
王敏, 马帅, 杨淑莉. 子宫血管周上皮样细胞肿瘤研究进展. 国际妇产科学杂志, 2019, 46(4): 449-452.
|
49. |
Utpatel K, Calvisi DF, Köhler G, et al. Complexity of PEComas: diagnostic approach, molecular background, clinical management. Pathologe, 2020, 41(Suppl 1): 9-19.
|
50. |
Shan W, Shi Y, Zhu Q, et al. Five cases of uterine perivascular epithelioid cell tumors (PEComas) and review of literature. Arch Gynecol Obstet, 2019, 299(1): 185-190.
|
51. |
Espinosa M, Roldán-Romero JM, Duran I, et al. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation. BMC Cancer, 2018, 18(1): 561.
|
52. |
Jia R, Jiang L, Zhou Y, et al. Clinical features of 18 perivascular epithelioid cell tumor cases. Medicine (Baltimore), 2020, 99(34): e21659.
|
53. |
Kenerson H, Folpe AL, Takayama TK, et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol, 2007, 38(9): 1361-1371.
|
54. |
孙文雄, 吴日超, 郑贤静, 等. 宫颈血管周上皮样细胞肿瘤 1 例. 山东大学学报(医学版), 2022, 60(9): 125-128.
|
55. |
Gu X, Yu JJ, Ilter D, et al. Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis. Proc Natl Acad Sci U S A, 2013, 110(37): 14960-14965.
|
56. |
Sanfilippo R, Fabbroni C, Fucà G, et al. Addition of antiestrogen treatment in patients with malignant PEComa progressing to mTOR inhibitors. Clin Cancer Res, 2020, 26(20): 5534-5538.
|
57. |
Shen Q, Rao Q, Xia QY, et al. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features. Virchows Arch, 2014, 465(5): 607-613.
|
58. |
Xu J, Gong XL, Wu H, et al. Case report: gastrointestinal PEComa with TFE3 rearrangement treated with anti-VEGFR TKI apatinib. Front Oncol, 2020, 10: 582087.
|
59. |
Agaram NP, Sung YS, Zhang L, et al. Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol, 2015, 39(6): 813-825.
|
60. |
Pivovarcikova K, Grossmann P, Alaghehbandan R, et al. TFE3-fusion variant analysis defines specific clinicopathologic associations amog Xp11 translocation cancers. Am J Surg Pathol, 2017, 41(1): 138-140.
|
61. |
Wang XT, Xia QY, Ni H, et al. Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum. Histopathology, 2016, 69(3): 450-458.
|
62. |
王小桐, 章如松, 李锐, 等. 伴有色素分化的 Xp11 易位性肿瘤的临床病理学特征. 中华病理学杂志, 2019, 48(12): 945-950.
|
63. |
欧阳慧钰. 非转移性黑色素瘤糖蛋白 B 在不同类型肿瘤中的作用. 广西医科大学学报, 2017, 34(6): 936-938.
|
64. |
Sanfilippo R, Jones RL, Blay JY, et al. Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas). Clin Cancer Res, 2019, 25(17): 5295-5300.
|
65. |
李永芳, 王亮. 肝脏血管周围上皮样肿瘤一例. 中国临床案例成果数据库, 2021, 3(1): E204-E204.
|